Literature DB >> 15784690

Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells.

Ofelia A Olivero1, Agueda M Tejera, Juan J Fernandez, Barbara J Taylor, Shreyasi Das, Rao L Divi, Miriam C Poirier.   

Abstract

Antiretroviral therapy for the human immunodeficiency virus-1 (HIV-1) typically includes two nucleoside reverse transcriptase inhibitors (NRTIs). 3'-Azido-3'-deoxythymidine (AZT, Zidovudine) plus 2'-deoxy-3'-thiacytidine (3TC, Lamivudine) is a combination that is used frequently. The NRTIs are mutagenic nucleoside analogs that become incorporated into DNA and terminate replication. We therefore hypothesized that exposure to this class of drug may alter cell cycle parameters. We used flow cytometry to examine the cell cycle in human epithelioid carcinoma (HeLa) cells exposed to AZT and 3TC alone, as well as a series of AZT/3TC dose combinations: (A) 125.0 microM AZT/12.5 microM 3TC; (B) 250.0 microM AZT/25.0 microM 3TC; and (C) 500 microM AZT/50 microM 3TC. At 24 h, at all doses, there was a good cell viability (>/=68%), and incorporation of AZT into nuclear DNA. Using flow cytometry, a dose-related increase in the percentage of cells in S phase, from 9.5% with no drug, to 36.0% with dose C, was observed in cells exposed for 24 h (P = 0.001, ANOVA). A concomitant decrease in the percentage of cells in G(1) phase, from 82.6% with no drug to 58.5% with dose C, was observed in cells exposed for 24 h (P = 0.017, ANOVA). A similar S phase arrest was seen in cells exposed to 125, 250 and 500 microM AZT alone, but there was no S phase alteration with 50 microM 3TC alone, suggesting that AZT is responsible for the accumulation of cells in S phase. To elucidate the accumulation of cells in S phase and explore the cell cycle gene expression changes induced by AZT and 3TC, we used c-DNA microarray, Cell Cycle Super Array and real-time PCR. There was a strong upregulation of the DNA damage-inducible transcript 3 (DDIT3 or GADD153) in NRTI-exposed cells. In addition, AZT induced an upregulation of cyclin D1 accompanied by a downregulation of the cyclin D1-associated inhibitors P18 and P57, and the G(1)-S check point gene P21, the net effect of which would be to foster a cell progression into S phase. Cyclin A2 was down-regulated in cells exposed to AZT, suggesting a block in S-G(2)-M progression that would also be consistent with the accumulation of cells in S phase. Overall, the study demonstrates that AZT, but not 3TC, causes an arrest of cells in S phase with a consistent alteration in the expression of several cell cycle genes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15784690     DOI: 10.1093/mutage/gei019

Source DB:  PubMed          Journal:  Mutagenesis        ISSN: 0267-8357            Impact factor:   3.000


  26 in total

1.  Centrosomal amplification and aneuploidy induced by the antiretroviral drug AZT in hamster and human cells.

Authors:  Jennifer P Borojerdi; Jessica Ming; Catherine Cooch; Yvona Ward; Cristina Semino-Mora; Mia Yu; Hannan M Braun; Barbara J Taylor; Miriam C Poirier; Ofelia A Olivero
Journal:  Mutat Res       Date:  2009-03-24       Impact factor: 2.433

2.  Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells.

Authors:  Yuanhong Liao; Jianya Ling; Guoying Zhang; Fengjun Liu; Shengce Tao; Zeguang Han; Saijuan Chen; Zhu Chen; Huangying Le
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  Non-AIDS-defining cancers among HIV-infected patients.

Authors:  James Cutrell; Roger Bedimo
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

4.  Deficiency in DNA damage response, a new characteristic of cells infected with latent HIV-1.

Authors:  Dorota Piekna-Przybylska; Gaurav Sharma; Sanjay B Maggirwar; Robert A Bambara
Journal:  Cell Cycle       Date:  2017-04-07       Impact factor: 4.534

5.  A computational model of mitochondrial AZT metabolism.

Authors:  Patrick C Bradshaw; Jiaxin Li; David C Samuels
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

6.  Human inter-individual variability in metabolism and genotoxic response to zidovudine.

Authors:  Ofelia A Olivero; Jessica M Ming; Shreyasi Das; Irma L Vazquez; Diana L Richardson; Ainsley Weston; Miriam C Poirier
Journal:  Toxicol Appl Pharmacol       Date:  2007-12-14       Impact factor: 4.219

7.  Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy.

Authors:  Yugal Behl; Padmaja Krothapalli; Tesfahun Desta; Amanda DiPiazza; Sayon Roy; Dana T Graves
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

8.  Interference of cell cycle progression by zidovudine and lamivudine in NIH 3T3 cells.

Authors:  Jia-Long Fang; Lynda J McGarrity; Frederick A Beland
Journal:  Mutagenesis       Date:  2008-10-20       Impact factor: 3.000

9.  Long-term exposure to zidovudine delays cell cycle progression, induces apoptosis, and decreases telomerase activity in human hepatocytes.

Authors:  Jia-Long Fang; Frederick A Beland
Journal:  Toxicol Sci       Date:  2009-06-18       Impact factor: 4.849

10.  Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells.

Authors:  Ofelia A Olivero; Irma L Vazquez; Catherine C Cooch; Jessica Ming; Emily Keller; Mia Yu; Jennifer P Borojerdi; Hannan M Braun; Edward McKee; Miriam C Poirier
Journal:  Toxicol Sci       Date:  2010-01-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.